News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arakis Ltd. £28M Third Round Enough To Last Until 2007


10/19/2005 5:10:10 PM

Arakis Ltd. raised £29 million (US$52 million) in its third funding round, providing enough money to take the company to 2007 and allowing it to start U.S. and European Phase III trials of AD 923 in cancer breakthrough pain.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES